• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PROG

PROG

Biora Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.88

-0.03 (-3.47%)

Company Profile

CEO

Harry Stylli

IPO Date

2020-06-19

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.90

Prev. Close

$0.92

Day Low

$0.84

Day High

$0.92

52W Low

$0.63

52W High

$6.20

Market Cap

$0.01B

Volume

2.78M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

15.4%

Avg Negative

3.0%

Avg Neutral

81.8%

News Feed

Progenity Announces Appointment of Surbhi Sarna to its Board of Directors

GlobeNewsWire·6/30/2021·↑ positive

Hot Penny Stocks to Buy in 2021? Check These 7 Out Right Now

PennyStocks·6/25/2021·↓ negative

Progenity Establishes Inflammatory Bowel Disease Clinical Advisory Board

GlobeNewsWire·6/17/2021·↑ positive

Implied Volatility Surging for Progenity (PROG) Stock Options

Zacks Investment Research·6/15/2021·↑ positive

Progenity to Participate in the Raymond James 2021 Human Health Innovation Conference

GlobeNewsWire·6/15/2021·↑ positive

Hot Penny Stocks to Buy Under $5? 3 You Might Not Have Heard Of

PennyStocks·6/12/2021·↓ negative

Progenity's Targeted Delivery Of Adalimumab Shows Encouraging Action In Animal Models Induced With Colitis

Benzinga·5/26/2021·↑ positive

Progenity Announces Poster Presentations at Digestive Disease Week 2021

GlobeNewsWire·5/24/2021·↑ positive

Progenity Joins Global Call to Raise Awareness of Preeclampsia in Pregnancy on World Preeclampsia Day – May 22nd

GlobeNewsWire·5/21/2021·↑ positive

Progenity, Inc. (PROG) CEO Dr. Harry Stylli on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/13/2021·↓ negative